|
1
|
Does prior percutaneous coronary intervention adversely affect early and mid-term survival after coronary artery surgery?
|
JACC Cardiovasc Interv
|
2009
|
1.61
|
|
2
|
May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association.
|
Stroke
|
2009
|
1.58
|
|
3
|
Survival of elderly patients undergoing percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock.
|
JACC Cardiovasc Interv
|
2009
|
1.52
|
|
4
|
Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation.
|
Int J Cardiol
|
2010
|
1.50
|
|
5
|
Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: analysis of the Melbourne Interventional Group registry.
|
Eur J Heart Fail
|
2011
|
1.41
|
|
6
|
Unusual case of recurrent renal artery stenosis: lessons to learn.
|
Kidney Int
|
2008
|
1.40
|
|
7
|
Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.
|
Br J Pharmacol
|
2010
|
1.39
|
|
8
|
Rho-kinase inhibition: a novel therapeutic target for the treatment of cardiovascular diseases.
|
Drug Discov Today
|
2010
|
1.24
|
|
9
|
Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience.
|
Catheter Cardiovasc Interv
|
2011
|
1.20
|
|
10
|
Left atrial appendage exclusion: state-of-the-art.
|
Catheter Cardiovasc Interv
|
2010
|
1.12
|
|
11
|
Subjects at risk of discontinuation of lipid-lowering agents: a 6-month cohort study among 12,875 patients in a chinese population.
|
Clin Ther
|
2011
|
1.10
|
|
12
|
Albumin levels predict survival in patients with heart failure and preserved ejection fraction.
|
Eur J Heart Fail
|
2011
|
1.07
|
|
13
|
Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre™ device) in a canine model.
|
Int J Cardiol
|
2013
|
0.97
|
|
14
|
The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.
|
Am Heart J
|
2009
|
0.96
|
|
15
|
Role of warfarin pharmacogenetic testing in clinical practice.
|
Pharmacogenomics
|
2010
|
0.92
|
|
16
|
Images in cardiovascular medicine. Giant left circumflex coronary artery aneurysm with arteriovenous fistula to the coronary sinus.
|
Circulation
|
2008
|
0.90
|
|
17
|
Venous and arterial disease in inflammatory bowel disease.
|
J Gastroenterol Hepatol
|
2013
|
0.90
|
|
18
|
The mystery of coronary artery spasm.
|
Heart Lung Circ
|
2006
|
0.87
|
|
19
|
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
|
Br J Clin Pharmacol
|
2011
|
0.87
|
|
20
|
Coil embolization of an iatrogenic coronary artery to cardiac vein fistula after rotational atherectomy.
|
J Interv Cardiol
|
2008
|
0.86
|
|
21
|
Marantic endocarditis presenting as recurrent arterial embolisation.
|
Int J Cardiol
|
2007
|
0.86
|
|
22
|
Measuring health related quality of life in coronary heart disease: the importance of feeling well.
|
Int J Cardiol
|
2010
|
0.86
|
|
23
|
Current status of rho-associated kinases (ROCKs) in coronary atherosclerosis and vasospasm.
|
Cardiovasc Hematol Agents Med Chem
|
2009
|
0.85
|
|
24
|
Quality of life after percutaneous coronary intervention in the elderly with acute coronary syndrome.
|
Int J Cardiol
|
2010
|
0.85
|
|
25
|
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease.
|
Clin Cardiol
|
2013
|
0.84
|
|
26
|
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes.
|
Int J Cardiol
|
2010
|
0.84
|
|
27
|
Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling.
|
Cardiovasc Res
|
2013
|
0.83
|
|
28
|
The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome.
|
Clin Cardiol
|
2011
|
0.83
|
|
29
|
An armband wearable device for overnight and cuff-less blood pressure measurement.
|
IEEE Trans Biomed Eng
|
2014
|
0.82
|
|
30
|
Dabigatran compared with warfarin for stroke prevention with atrial fibrillation: experience in Hong Kong.
|
Clin Cardiol
|
2012
|
0.82
|
|
31
|
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data.
|
Pharmacol Ther
|
2010
|
0.82
|
|
32
|
Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry.
|
Med J Aust
|
2008
|
0.81
|
|
33
|
Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension.
|
PLoS One
|
2013
|
0.81
|
|
34
|
Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting.
|
Cardiovasc Hematol Agents Med Chem
|
2008
|
0.80
|
|
35
|
Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.
|
Pharmacol Ther
|
2009
|
0.80
|
|
36
|
Attenuation of systolic blood pressure and pulse transit time hysteresis during exercise and recovery in cardiovascular patients.
|
IEEE Trans Biomed Eng
|
2014
|
0.80
|
|
37
|
Bleeding of new oral anticoagulants for stroke prevention in atrial fibrillation: a meta-analysis of randomized controlled trials.
|
Cardiovasc Drugs Ther
|
2013
|
0.80
|
|
38
|
Transcatheter renal artery sympathetic denervation for resistant hypertension: an old paradigm revisited.
|
Int J Cardiol
|
2012
|
0.80
|
|
39
|
Proton pump inhibitor and clopidogrel interaction: the case for watchful waiting.
|
J Gastroenterol Hepatol
|
2010
|
0.79
|
|
40
|
Investigational devices for mitral regurgitation: state of the art.
|
Expert Rev Med Devices
|
2011
|
0.79
|
|
41
|
Management of access site and systemic complications of percutaneous coronary and peripheral interventions.
|
J Invasive Cardiol
|
2008
|
0.79
|
|
42
|
Risk and management of upper gastrointestinal bleeding associated with prolonged dual-antiplatelet therapy after percutaneous coronary intervention.
|
Cardiovasc Revasc Med
|
2009
|
0.79
|
|
43
|
Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
|
Clin Cardiol
|
2012
|
0.79
|
|
44
|
The clinical outcome of restricting drug-eluting stents to patients at highest risk of restenosis.
|
EuroIntervention
|
2006
|
0.79
|
|
45
|
Renal artery revascularization: collaborative approaches for specialists.
|
Adv Chronic Kidney Dis
|
2008
|
0.78
|
|
46
|
Wearable cuff-less PTT-based system for overnight blood pressure monitoring.
|
Conf Proc IEEE Eng Med Biol Soc
|
2013
|
0.78
|
|
47
|
Correlates of carotid stenosis in patients undergoing coronary artery bypass grafting--a case control study.
|
Vasc Med
|
2009
|
0.78
|
|
48
|
Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.
|
Cardiovasc Ther
|
2011
|
0.77
|
|
49
|
Cardiovascular medication use following percutaneous coronary intervention: the Australian experience.
|
Cardiovasc Ther
|
2014
|
0.77
|
|
50
|
Enhanced detection of patent foramen ovale by systematic transthoracic saline contrast echocardiography.
|
Int J Cardiol
|
2010
|
0.77
|
|
51
|
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation--a real patient data analysis in a Hong Kong teaching hospital.
|
Clin Cardiol
|
2013
|
0.77
|
|
52
|
The no-reflow phenomenon in the coronary circulation.
|
Cardiovasc Hematol Agents Med Chem
|
2009
|
0.77
|
|
53
|
Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
|
Heart Lung Circ
|
2007
|
0.76
|
|
54
|
Treatment of renal artery in-stent restenosis with sirolimus-eluting stents.
|
Vasc Med
|
2009
|
0.76
|
|
55
|
Isolated heart models for studying cardiac electrophysiology: a historical perspective and recent advances.
|
J Basic Clin Physiol Pharmacol
|
2017
|
0.75
|
|
56
|
Clinical manifestation and current management of patent foramen ovale.
|
Expert Rev Cardiovasc Ther
|
2009
|
0.75
|
|
57
|
Left atrial remodeling and reduced atrial pump function after chronic right ventricular apical pacing in patients with preserved ejection fraction.
|
Int J Cardiol
|
2011
|
0.75
|
|
58
|
Antiplatelet therapy for the primary and secondary prevention of cerebrovascular events in patients with extracranial carotid artery disease.
|
J Vasc Surg
|
2009
|
0.75
|
|
59
|
Coherence analysis of invasive blood pressure and its noninvasive indicators for improvement of cuffless measurement accuracy.
|
Conf Proc IEEE Eng Med Biol Soc
|
2017
|
0.75
|
|
60
|
What's Old is New Again - A review of the current evidence of colchicine in cardiovascular medicine.
|
Curr Cardiol Rev
|
2016
|
0.75
|
|
61
|
Protection devices and thrombectomy for native coronary artery ST-elevation myocardial infarction.
|
J Invasive Cardiol
|
2008
|
0.75
|
|
62
|
Comprehensive evaluation and medical management of infrainguinal peripheral artery disease: "when to treat, when not to treat".
|
Tech Vasc Interv Radiol
|
2010
|
0.75
|
|
63
|
Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.
|
Expert Opin Drug Metab Toxicol
|
2012
|
0.75
|
|
64
|
Current status of pharmacological thrombolytic therapy and mechanical thrombectomy for the treatment of acute deep venous thrombosis.
|
Cardiovasc Hematol Agents Med Chem
|
2009
|
0.75
|
|
65
|
Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting.
|
Int J Cardiol
|
2012
|
0.75
|
|
66
|
Noninvasive Characterization of Vascular Tone by Model-Based System Identification in Healthy and Heart Failure Patients.
|
Ann Biomed Eng
|
2015
|
0.75
|
|
67
|
Images in cardiovascular medicine. Adventitial fibromuscular dysplasia of the renal artery: management challenges of nonatherosclerotic renal artery stenosis.
|
Circulation
|
2009
|
0.75
|
|
68
|
Cardiovascular readmissions and excess costs following percutaneous coronary intervention in patients with chronic kidney disease: data from a large multi-centre Australian registry.
|
Int J Cardiol
|
2013
|
0.75
|